Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Status: | Published |
| Official URL: | https://doi.org/10.1016/j.ijpharm.2018.09.024 |
| Journal or Publication Title: | International Journal of Pharmaceutics |
| Volume: | 551 |
| Number: | 1-2 |
| Page Range: | pp. 158-165 |
| Date: | 2018 |
| Divisions: | Tuberculosis |
| Depositing User: | General Admin |
| Identification Number: | 10.1016/j.ijpharm.2018.09.024 |
| ISSN: | 03785173 |
| Date Deposited: | 03 Jan 2021 22:59 |
| Abstract: | Nebulization is currently used for delivery of antibiotics for respiratory infections. Bacteriophages (or phages) are effective predators of pathogens including Pseudomonas aeruginosa commonly found in the lungs of patients with cystic fibrosis (CF). It is known that phages and antibiotics can potentially show synergistic antimicrobial effect on bacterial killing. In the present study, we investigated synergistic antimicrobial effect of phage PEV20 with five different antibiotics against three P. aeruginosa strains isolated from sputum of CF patients. The antibiotics included ciprofloxacin, tobramycin, colistin, aztreonam and amikacin, which are approved by U.S Food and Drug Administration (FDA) for inhaled administration. Phage and antibiotic synergy was determined by assessing bacterial killing performing time-kill studies. Among the different phage-antibiotic combinations, PEV20 and ciprofloxacin exhibited the most synergistic effect. Two phage-ciprofloxacin combinations, containing 1/4 and 1/2 of the minimum inhibitory concentration (MIC) of ciprofloxacin against P. aeruginosa strains FADD1-PA001 (A) and JIP865, respectively were aerosolized using both air-jet and vibrating mesh nebulizers and the synergistic antibacterial activity was maintained after nebulization. Air-jet nebulizer generated droplets with smaller volume median diameters (3.6-3.7 µm) and slightly larger span (2.3-2.4) than vibrating mesh nebulizers (5.1-5.3 µm; 2.1-2.2), achieving a higher fine particle fraction (FPF) of 70%. In conclusion, nebulized phage PEV20 and ciprofloxacin combination shows promising antimicrobial and aerosol characteristics for potential treatment of respiratory tract infections caused by drug-resistant P. aeruginosa. Keywords: Antibiotics; Bacteriophage; Ciprofloxacin; Cystic fibrosis; Inhalation; Nebulizer; Phage therapy; Pseudomonas aeruginosa; Respiratory tract infection. Copyright © 2018 Elsevier B.V. All rights reserved. |
| Creators: | Creators Email Lin, Yu UNSPECIFIED Chang, Rachel Yoon Kyung UNSPECIFIED Britton, Warwick J. UNSPECIFIED Morales, Sandra UNSPECIFIED Kutter, Elizabeth UNSPECIFIED Chan, Hak-Kim UNSPECIFIED |
| Last Modified: | 03 Jan 2021 22:59 |
| URI: | https://eprints.centenary.org.au/id/eprint/499 |
Actions (login required)
 |
View Item |
